Muvon
The leadership from MUVON Therapeutics AG will be attending JP Morgan Healthcare week in Jan 2023
The leadership from MUVON Therapeutics AG will be attending JP Morgan the premier life sciences investment conference in San Francisco...
top of page
Search
Muvon
- Nov 16, 2022
- 3 min
MUVON Therapeutics announces appointments to its Board of Directors and Scientific Advisory Board
Zurich, Switzerland, November 16, 2022 – MUVON Therapeutics announces the appointment of Dr Branimir Brankov to its Board of Directors...
67 views0 comments
Muvon
- Oct 27, 2022
- 3 min
Muvon Therapeutics Announces First Patient Enrolled in Phase II Clinical Study
Zurich, Switzerland, October 27, 2022 – Muvon Therapeutics AG, an innovative clinical-stage biotechnology company, today announced that...
110 views0 comments
Muvon
- Sep 19, 2022
- 1 min
CEO Deana Mohr honored to present MUVON to Prof. Shinya Yamanaka, godfather of iPSCs
MUVONs CEO Deana Mohr had the great honor to present MUVONs technology and visions to Prof. Shinya Yamanaka before his public lecture at...
69 views0 comments
Muvon
- Sep 8, 2022
- 3 min
Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with SUI
Zurich, Switzerland, September 8, 2022 -- Muvon Therapeutics AG, an innovative clinical-stage biotechnology company announced results...
291 views0 comments
Muvon
- Apr 21, 2022
- 1 min
MUVON Therapeutics is supported by the Lichtsteiner Foundation
MUVON Therapeutics was selected by the Lichtsteiner Foundation to become a part of their supported community of pioneering innovators....
124 views0 comments
Muvon
- Apr 19, 2022
- 1 min
MUVON's CEO Deana Mohr featured in Top 30 In Vivo's Rising Leaders 2022
MUVON Therapeutics, a spin-off from the University of Zurich developing a platform technology for the regeneration of skeletal muscle...
178 views0 comments
Muvon
- Feb 10, 2022
- 1 min
CEO Deana Mohr presented MUVON in interview for BioInnovation Spotlight
Our CEO Deana Mohr had the great opportunity to present MUVONs vision and innovative regenerative cell therapy in an interview for...
118 views0 comments
Muvon
- Jan 27, 2022
- 1 min
Translation and automation hurdles for cell therapies
Informative article published in BioInsights, written by our CSO Jenny Prange and our innovation manager Beatrix Rauch Schmid. This...
169 views0 comments
Muvon
- Sep 27, 2021
- 1 min
MUVON wins second place at IFAS Innovation Challenge 2021
MUVON Therapeutics was selected as one of twelve finalists for 2021's IFAS Innovation Challenge and placed second in the final pitching...
113 views0 comments
Muvon
- Jun 10, 2021
- 1 min
Deana Mohr wins spot in Venture Leaders Medtech 2021
MUVON Therapeutics CEO Deana Mohr was selected as one of ten Venture Leaders in Medtech to represent the Swiss National Startup Team in...
174 views0 comments
Muvon
- Jun 2, 2021
- 1 min
MUVON featured by Startupticker
MUVON was featured in an article by Startupticker describing our regenerative approach for the treatment of incontinence and the progress...
55 views0 comments
Muvon
- Apr 29, 2021
- 1 min
MUVON Therapeutics selected as finalist for the 2021 >>venture>> Startup Competition
MUVON is excited to have been selected as one of the top 10 startups in the Health and Nutrition vertical of the 2021 >>venture>> startup...
80 views0 comments
Muvon
- Apr 21, 2021
- 1 min
MUVON Therapeutics selected for Tech4Eva accelerator program
MUVON Therapeutics is proud to have been selected as one of 30 start-ups and projects from around the world to join Switzerlands first...
55 views0 comments
Muvon
- Apr 1, 2021
- 1 min
MUVON is being accelerated by Wyss Zurich
MUVON Therapeutics is proud to announce the acceptance as a Wyss Zurich Project starting April 2021. The Wyss Zurich is a joint...
120 views0 comments
Muvon
- Dec 21, 2020
- 1 min
The Beginning of the MUVON Story
In October 2020 MUVON Therapeutics Ltd. was founded. The technology behind MUVON was developed over the past decade at the University of...
96 views0 comments
bottom of page